Global pharmaceutical leader Sanofi successfully secured the cancellation of the disputed domain <sanofimywork.com> under WIPO UDRP proceedings. The domain, which combined Sanofi’s trademark with the descriptive phrase ‘mywork’, was registered in bad faith and held passively by the respondent. Panelist Christelle Vaval ruled that the respondent lacked legitimate rights or interests and ordered the domain canceled.
Case Snapshot
| Case Number | D2025-5256 |
|---|---|
| Complainant | Sanofi |
| Respondent | PHAM VAN THAI, Domain Service |
| Disputed Domain | sanofimywork.com |
| Threat Tactic | Brand Plus Keyword |
| Decision Date | 2026-02-03 |
| Panelist | Christelle Vaval |
| Outcome | Cancellation |
| Official Source | https://www.wipo.int/amc/en/domains/search/text.jsp?case=D2025-5256 |
Exploitation of Corporate-Themed Keywords and Latent Cybersecurity Threats
The registration of <sanofimywork.com> illustrates the specific business threat of corporate impersonation targeting internal operational infrastructure. By combining the distinctive SANOFI trademark with the descriptive suffix "mywork," the registrant created a high-risk vector capable of deceiving employees, contractors, and third-party partners into believing the domain was an official internal access portal or intranet login page. Although the website remained inactive and resolved to an error page at the time of the dispute, the specific choice of the "mywork" keyword signals an orientation toward internal corporate systems rather than consumer-facing services, elevating the potential for trust-based exploitation.
While no active phishing campaigns or actual system breaches were documented in the case record, the passive holding of such corporate-themed domains presents a severe latent security risk. Had the domain been configured with Mail Exchange (MX) records, the registrant could have executed targeted credential-harvesting campaigns or deployed deceptive email communications mimicking internal corporate updates. Brand owners face substantial operational overhead in maintaining continuous digital monitoring systems to detect these registrations immediately, as neutralizing these threats defensively—prior to active exploitation—is critical to preventing potential security compromises and protecting corporate network integrity.
Sanofi’s response timeline highlights the necessity of rapid intervention. Filing a WIPO UDRP complaint on December 16, 2025, a mere six days after the domain was registered on December 10, 2025, demonstrates that proactive enforcement is vital for mitigating brand-plus-keyword risks. Relying on reactive measures after an active attack occurs exposes an organization to severe financial and reputational damage. Consequently, corporate security teams must establish immediate action protocols to neutralize unauthorized domains incorporating internal administrative keywords before they can be weaponized in phishing or identity fraud schemes.
Panelist Analysis of Confusing Similarity, Legitimate Interests, and Bad Faith
In evaluating the first element of the Policy, Panelist Christelle Vaval concluded that the disputed domain name <sanofimywork.com> is confusingly similar to the Complainant’s registered SANOFI trademark. The Panel noted that the SANOFI trademark is fully reproduced and stands as the dominant aspect of the disputed domain name. The addition of the descriptive corporate phrase ‘mywork’ does not prevent a finding of confusing similarity, as the highly distinctive and famous SANOFI mark—which Sanofi registered in both the European Union and the United States in 2012—remains the primary focal point of the string. This decision reinforces established UDRP precedent that appending generic or descriptive terms to a recognized trademark does not diminish the likelihood of confusion.
Regarding rights or legitimate interests, the Panelist ruled that the Respondent, PHAM VAN THAI, Domain Service, possessed no authorization or license to utilize the SANOFI trademark. The Complainant successfully established a prima facie case by demonstrating that the Respondent is not affiliated with Sanofi and has not been licensed to use its intellectual property. Furthermore, the Panel found that the inactive status of the disputed domain name, which resolved only to an error page, serves as clear evidence that the Respondent has no genuine interest or legitimate offering of goods or services associated with the address. Because the Respondent did not reply to the Complainant’s contentions, the prima facie case remained entirely unrebutted, satisfying the second element of the Policy.
The Panel’s bad faith determination relied heavily on the global reputation and distinctive nature of the SANOFI mark. The Panelist concluded that the Respondent must have been fully aware of Sanofi’s trademark when registering the domain name on December 10, 2025, and that the registration was designed to create a likelihood of confusion or an false impression of association with the Complainant. Even though the website remained inactive and no phishing activities or direct ransom demands were documented, the Panel applied the doctrine of passive holding. Under this doctrine, keeping a domain inactive does not prevent a finding of bad faith registration and use when the targeted trademark holds a worldwide reputation, making it highly improbable that the Respondent could have chosen the domain name for any benign or legitimate reason.
Strategic Evaluation of Sanofi’s Rapid Enforcement and Evidentiary Success
Sanofi’s successful strategy in case D2025-5256 centered on an exceptionally rapid filing timeline and a robust establishment of its prior trademark rights. By initiating the UDRP complaint on December 16, 2025—just six days after the domain <sanofimywork.com> was registered—Sanofi proactively neutralized the threat before the domain could be configured for phishing or credential harvesting. The complainant presented clear evidence of its long-standing trademark rights, including its registrations in the European Union and the United States from 2012. This temporal priority, combined with the global fame of the SANOFI mark, made it impossible for the respondent, PHAM VAN THAI, Domain Service, to reasonably claim any rights or legitimate interests, establishing a powerful prima facie case that remained entirely unrebutted.
Furthermore, the strategy demonstrates how brand owners can successfully navigate the passive holding doctrine when dealing with corporate-themed keyword squatted domains. Although the disputed domain remained inactive and resolved to an error page without active MX records or documented phishing attempts, Sanofi successfully argued that the incorporation of the "mywork" suffix was designed to mimic an internal employee portal. The panelist, Christelle Vaval, accepted that the famous and distinctive nature of the SANOFI trademark meant the respondent must have been aware of the brand during registration. This outcome confirms that brand owners do not need to wait for active security breaches or direct communication from a respondent to obtain a cancellation, provided they can demonstrate that the brand-plus-keyword combination creates an immediate, highly plausible risk of corporate impersonation.
Practical Recommendations
- Implement proactive domain monitoring specifically configured to detect brand-plus-keyword registrations containing internal corporate terms (e.g., ‘work’, ‘mywork’, ‘sso’, ‘login’, ‘portal’) to mitigate employee-targeting impersonation risks early.
- Set up continuous DNS and MX record monitoring for newly registered corporate-themed domain variations to identify if passive holdings are being prepped for active phishing or credential harvesting campaigns.
- Formulate a rapid-response UDRP filing template targeting ‘passive holding’ of famous trademarks, utilizing WIPO precedents like D2025-5256 to efficiently secure cancellation without waiting for a website to become active or malicious.
- Coordinate with internal IT security teams to preemptively block traffic and emails associated with newly detected high-risk domains at the Secure Web Gateway (SWG) and email gateway levels while the UDRP dispute is pending.
- Evaluate and execute defensive registrations for critical corporate-themed domain variations (such as [Brand]portal.com or [Brand]sso.com) to permanently deny bad actors access to high-trust employee keywords.
Frequently Asked Questions (FAQ)
Why was the domain ‘sanofimywork.com’ considered confusingly similar to Sanofi’s trademark?
The Panel determined that the disputed domain name reproduces the ‘SANOFI’ trademark in its entirety as the dominant aspect, creating a likelihood of confusion by falsely implying an association with the company.
How did the Panel establish that the Respondent lacked legitimate rights or interests?
The Panel noted that Sanofi never authorized or licensed the use of its trademark to the Respondent. Furthermore, the domain’s inactive status and the absence of any rebuttal from the Respondent confirmed a lack of any genuine or legitimate interest.
What evidence proved the Respondent acted in bad faith?
Bad faith was inferred from the Respondent’s registration of a domain incorporating a famous, distinctive pharmaceutical trademark, combined with its passive holding, suggesting an intent to exploit the brand for potential future deception.
What is the primary business risk associated with this type of domain registration?
The registration of ‘brand-plus-keyword’ domains like ‘sanofimywork.com’ poses a significant risk of corporate impersonation, as such domains can be leveraged for credential harvesting or phishing attacks targeting employees who mistake them for legitimate internal portals.
Is your brand being leveraged by keyword-squatting domains?
The registration of domains combining your trademark with internal or functional keywords—like ‘mywork’ or ‘portal’—creates significant impersonation risks. Discover how to identify and neutralize these threats before they are weaponized for phishing or fraud.
This case note is for informational purposes only and is not legal advice.
